Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results
about
Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophyHuman adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophyMonoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies.Mitochondrial dysfunction and defective autophagy in the pathogenesis of collagen VI muscular dystrophies.Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets.Discovery, Synthesis, and Optimization of Diarylisoxazole-3-carboxamides as Potent Inhibitors of the Mitochondrial Permeability Transition Pore.Sarcolemmal specific collagen VI deficient myopathy in a Labrador RetrieverResults of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies.Autophagy activation in COL6 myopathic patients by a low-protein-diet pilot trial.Ultrastructural changes in muscle cells of patients with collagen VI-related myopathies.Mitochondrial channels: ion fluxes and more.Cyclosporin A Promotes in vivo Myogenic Response in Collagen VI-Deficient Myopathic Mice.NIM811, a cyclophilin inhibitor without immunosuppressive activity, is beneficial in collagen VI congenital muscular dystrophy models.Body composition, muscle strength, and physical function of patients with Bethlem myopathy and Ullrich congenital muscular dystrophy.
P2860
Q28085320-CE90701F-07A1-4100-A3DE-2823F75C44A6Q33745931-6FD1945B-8F74-4EC4-BCDF-A1F929E14FB6Q34266732-F90C76F0-C877-4F29-BACE-79EBDB618C21Q34338854-0810AABA-7658-48E5-8E8E-0BD56D6B9406Q35040061-E7840442-52F7-414A-90E2-930C6836BDFBQ36358813-968731E3-64BD-4AC8-9819-A3FA92E9581DQ36975280-5AC0ADE8-3861-4157-B2BC-8464FE23E733Q37446660-09C6930A-EC0A-41D9-83EE-3D49C1748F6EQ37520725-221460DD-56F2-4DA3-9668-7216D154B20BQ37613885-CF4880F1-60B2-46B4-9DC0-BE6CD04B2820Q38201407-06373BEA-6500-4671-9917-81E177091B2CQ42069294-46077FB4-99B6-44CE-B24C-65F554667B3DQ47073612-7BA0F2E9-8992-483F-B276-49CDBCE708D9Q54690359-4E850A3D-3E5B-469B-939A-2803E513BF34
P2860
Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results
@ast
Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results
@en
type
label
Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results
@ast
Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results
@en
prefLabel
Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results
@ast
Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results
@en
P2093
P2860
P50
P356
P1476
Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results
@en
P2093
Alessandra Ferlini
Alessia Angelin
Andrea Franchella
Annarita Armaroli
Francesca Gualandi
Maria Elena Michelini
Nadir Mario Maraldi
Paolo Bonaldo
Paolo Grumati
Patrizia Sabatelli
P2860
P304
P356
10.1155/2011/139194
P577
2011-10-17T00:00:00Z